105 related articles for article (PubMed ID: 12501502)
21. Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats.
Crews GM; Erickson L; Pan F; Fisniku O; Jang MS; Wynn C; Benediktsson H; Kobayashi M; Jiang H
Transplant Proc; 2005 May; 37(4):1926-8. PubMed ID: 15919506
[TBL] [Abstract][Full Text] [Related]
22. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
[TBL] [Abstract][Full Text] [Related]
23. The soluble transforming growth factor-beta receptor: advantages and applications.
Russo LM; Brown D; Lin HY
Int J Biochem Cell Biol; 2009 Mar; 41(3):472-6. PubMed ID: 18339576
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
Rolfe KJ; Irvine LM; Grobbelaar AO; Linge C
Wound Repair Regen; 2007; 15(6):897-906. PubMed ID: 18028139
[TBL] [Abstract][Full Text] [Related]
25. Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study.
de Groot-Kruseman HA; Mol WM; Niesters HG; Maat AP; van Gelder T; Balk AH; Weimar W; Baan CC
Transpl Int; 2003 Jan; 16(1):9-14. PubMed ID: 12545335
[TBL] [Abstract][Full Text] [Related]
26. [Review on transforming growth factor beta and repair of tissue injury].
Liu K; Qian YL; Fan ZH
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):283-6. PubMed ID: 12080819
[TBL] [Abstract][Full Text] [Related]
27. Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.
Helanterä I; Teppo AM; Koskinen P; Törnroth T; Grönhagen-Riska C; Lautenschlager I
Transpl Immunol; 2006 Jan; 15(3):217-21. PubMed ID: 16431289
[TBL] [Abstract][Full Text] [Related]
28. Relationship between subclinical rejection and genotype, renal messenger RNA, and plasma protein transforming growth factor-beta1 levels.
Hueso M; Navarro E; Moreso F; Beltrán-Sastre V; Ventura F; Grinyó JM; Serón D
Transplantation; 2006 May; 81(10):1463-6. PubMed ID: 16732186
[TBL] [Abstract][Full Text] [Related]
29. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
[TBL] [Abstract][Full Text] [Related]
30. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
31. TGFbeta-1 and the development of chronic graft nephropathy: relative roles of gene, mRNA and protein.
Morris-Stiff G
Ann R Coll Surg Engl; 2005 Sep; 87(5):326-30. PubMed ID: 16176689
[TBL] [Abstract][Full Text] [Related]
32. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
33. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
34. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
[TBL] [Abstract][Full Text] [Related]
35. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
36. Cytokines and chemokine gene expression in human kidney transplantation.
Hribova P; Kotsch K; Brabcova I; Vitko S; Volk HD; Lacha J
Transplant Proc; 2005 Mar; 37(2):760-3. PubMed ID: 15848523
[TBL] [Abstract][Full Text] [Related]
37. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
[TBL] [Abstract][Full Text] [Related]
38. beta6 integrin is up-regulated in chronic renal allograft dysfunction.
Sawada T; Abe M; Kai K; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Oct; 18(5):525-8. PubMed ID: 15344954
[TBL] [Abstract][Full Text] [Related]
39. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
[TBL] [Abstract][Full Text] [Related]
40. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients.
Amirzargar M; Yavangi M; Basiri A; Moghadam SH; Khosravi F; Solgi G; Gholiaf M; Khoshkho F; Dadaras F; Mahmmodi M; Ansaripour B; Amirzargar A; Nikbin B
Transplant Proc; 2007 May; 39(4):954-7. PubMed ID: 17524861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
